Paeoniflorin inhibits macrophage-mediated lung cancer metastasis

被引:28
|
作者
Wu Qi [1 ]
Chen Gang-Ling [2 ]
Li Ya-Juan [3 ]
Chen Yang [2 ]
Lin Fang-Zhen [2 ]
机构
[1] China Pharmaceut Univ, Res Dept Pharmacognosy, State Key Lab Nat Med, Nanjing 211198, Jiangsu, Peoples R China
[2] China Pharmaceut Univ, Dept Pharm Chinese Mat Med, Nanjing 211198, Jiangsu, Peoples R China
[3] Shanghai Univ Tradit Chinese Med, Murad Res Inst Modernized Chinese Med, Shanghai 201203, Peoples R China
基金
中国国家自然科学基金;
关键词
Paeoniflorin; Lung cancer; Metastasis; Alternatively activated macrophages; Tumor-associated macrophages; TUMOR; LYMPHANGIOGENESIS; ACTIVATION;
D O I
10.1016/S1875-5364(15)30098-4
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Alternatively activated macrophages are more frequently involved in tumor growth, angiogenesis, and immunosuppression. A previous study showed that paeoniflorin, the major active constituent of Paeonia lactiflora Pallas, can inhibit tumor growth and lung metastases of Lewis lung tumor-bearing mice. This study tried to investigate whether paeoniflorin inhibited lung cancer metastasis by inhibiting the alternative activation of macrophages (M2 macrophage). Using a viability assay, the cytotoxicity of paeoniflorin on Lewis lung cancer cells and peritoneal macrophages were investigated. In vitro scratch wound and in vivo lung metastasis experiments were used to test the ability to inhibit the migration of paeoniflorin and the function of M2 macrophages. Flow cytometry was performed to test the cell cycle of Lewis lung cancer cells, and to test the M2 macrophages in peritoneal macrophages and subcutaneous transplantable tumor. It was found that paeoniflorin showed no inhibitory effect on the growth of Lewis lung cancer cells and peritoneal macrophages of mouse in vitro. Paeoniflorin could attenuate the migration of LLC stimulated by alternatively activated macrophages (stimulated for 24 h and 48 h, paeoniflorin 1, 3, 10, 30, 100 mu mol.L-1, P < 0.01 or P < 0.05 vs control group). Paeoniflorin could decrease the cell populations at S phases (paeoniflorin 10, 30, 100 mu mol.L-1, P < 0.05 vs control group) and increase the cell populations at G0-G1 phases of Lewis lung cancer cells (paeoniflorin 100 mu mol.L-1, P < 0.05 vs control group) and reduce the numbers of M2 macrophages in peritoneal macrophages induced by]L-4 (paeoniflorin 1, 3, 10, 30, 100 mu mol.L-1, P < 0.01 vs Control group). Paeoniflorin could reduce lung metastasis of Lewis lung cancer cells xenograft and decrease the numbers of M2 macrophages in subcutaneous xenograft tumour in vivo (paeoniflorin 20, 40 mg.kg(-1), P < 0.01 vs control group). These results suggest that paeoniflorin could reduce lung metastasis of Lewis lung cancer cells xenograft partly through inhibiting the alternative activation of macrophages.
引用
收藏
页码:925 / 932
页数:8
相关论文
共 50 条
  • [31] MECHANISMS OF MACROPHAGE-MEDIATED TUMOR CYTOLYSIS
    KEY, ME
    HOYER, L
    BUCANA, C
    HANNA, MG
    ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY, 1982, 146 : 265 - 310
  • [32] ANANDAMIDE INHIBITS MACROPHAGE-MEDIATED KILLING OF TUMOR NECROSIS FACTOR-SENSITIVE CELLS
    CABRAL, GA
    TONEY, DM
    FISCHERSTENGER, K
    HARRISON, MP
    MARCIANOCABRAL, F
    LIFE SCIENCES, 1995, 56 (23-24) : 2065 - 2072
  • [33] Liver metastasis restrains immunotherapy efficacy via macrophage-mediated T cell elimination
    Jiali Yu
    Michael D. Green
    Shasha Li
    Yilun Sun
    Sara N. Journey
    Jae Eun Choi
    Syed Monem Rizvi
    Angel Qin
    Jessica J. Waninger
    Xueting Lang
    Zoey Chopra
    Issam El Naqa
    Jiajia Zhou
    Yingjie Bian
    Long Jiang
    Alangoya Tezel
    Jeremy Skvarce
    Rohan K. Achar
    Merna Sitto
    Benjamin S. Rosen
    Fengyun Su
    Sathiya P. Narayanan
    Xuhong Cao
    Shuang Wei
    Wojciech Szeliga
    Linda Vatan
    Charles Mayo
    Meredith A. Morgan
    Caitlin A. Schonewolf
    Kyle Cuneo
    Ilona Kryczek
    Vincent T. Ma
    Christopher D. Lao
    Theodore S. Lawrence
    Nithya Ramnath
    Fei Wen
    Arul M. Chinnaiyan
    Marcin Cieslik
    Ajjai Alva
    Weiping Zou
    Nature Medicine, 2021, 27 : 152 - 164
  • [34] Macrophage-mediated inflammation in metabolic disease
    Chawla, Ajay
    Nguyen, Khoa D.
    Goh, Y. P. Sharon
    NATURE REVIEWS IMMUNOLOGY, 2011, 11 (11) : 738 - 749
  • [35] Macrophage-mediated cholesterol handling in atherosclerosis
    Chistiakov, Dimitry A.
    Bobryshev, Yuri V.
    Orekhov, Alexander N.
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2016, 20 (01) : 17 - 28
  • [36] Nonresolving macrophage-mediated inflammation in malignancy
    Murray, Peter J.
    FEBS JOURNAL, 2018, 285 (04) : 641 - 653
  • [37] Role of Ferroportin in Macrophage-Mediated Immunity
    Johnson, Erin E.
    Sandgren, Andreas
    Cherayil, Bobby J.
    Murray, Megan
    Wessling-Resnick, Marianne
    INFECTION AND IMMUNITY, 2010, 78 (12) : 5099 - 5106
  • [38] STUDIES ON MECHANISM OF MACROPHAGE-MEDIATED CYTOTOXICITY
    ZIEGLER, FG
    LOHMANNMATTHES, ML
    FISCHER, H
    INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY, 1975, 48 (02): : 182 - 191
  • [39] Ligand-mediated cytoplasmic retention of the Ah receptor inhibits macrophage-mediated acute inflammatory responses
    Muku, Gulsum E.
    Lahoti, Tejas S.
    Murray, Iain A.
    Podolsky, Michael A.
    Smith, Kayla J.
    Hubbard, Troy D.
    Kuzu, Guray
    Gowda, Krishne
    Amin, Shantu G.
    Perdew, Gary H.
    LABORATORY INVESTIGATION, 2017, 97 (12) : 1471 - 1487
  • [40] SELECTIVE MECHANISM OF MACROPHAGE-MEDIATED CYTOTOXICITY
    HEMSWORTH, GR
    WOLFF, JS
    KRASKA, AR
    JENSEN, KE
    KENNEY, JW
    MISIUNAS, V
    JOURNAL OF THE RETICULOENDOTHELIAL SOCIETY, 1978, 24 (DEC): : A47 - A47